RCOR2 Inhibitors is a chemical class of compounds that primarily target the Reversing Cofactor of RE1 (RCOR2) protein, also known as CoREST2. These inhibitors are predominantly utilized in the field of molecular biology and epigenetics for research purposes. RCOR2, as a core component of the CoREST complex, plays a pivotal role in epigenetic regulation and gene expression control. Inhibitors within this class are designed to interfere with the normal function of RCOR2, ultimately modulating the epigenetic landscape of cells and influencing gene transcription.
The mechanisms of action for RCOR2 inhibitors are diverse and multifaceted. Some of these compounds may act as histone deacetylase (HDAC) inhibitors, preventing the removal of acetyl groups from histones. This leads to increased histone acetylation, a hallmark of transcriptionally active chromatin, and subsequently promotes gene expression. Other RCOR2 inhibitors may function by targeting DNA methyltransferases, causing alterations in DNA methylation patterns. By reducing DNA methylation, these inhibitors can activate genes that were previously silenced. Additionally, some compounds within this class may disrupt protein-protein interactions between RCOR2 and transcription factors, preventing the recruitment of RCOR2 to specific gene promoters and thereby influencing gene regulation
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
HDAC inhibitor that enhances histone acetylation, promoting gene expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, which can demethylate DNA and activate silenced genes. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
An HDAC inhibitor used in cancer therapy to modify gene expression. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
HDAC inhibitor with a role in epigenetic regulation and potential for cancer | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $260.00 $925.00 | 5 | |
Inhibits p300/CBP histone acetyltransferase, affecting acetylation of histones and gene expression. | ||||||
UNC1999 | 1431612-23-5 | sc-475314 | 5 mg | $142.00 | 1 | |
An inhibitor of the histone methyltransferase G9a, involved in histone methylation. | ||||||
EPZ6438 | 1403254-99-8 | sc-507456 | 1 mg | $66.00 | ||
A selective inhibitor of EZH2, an enzyme involved in histone methylation. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
DNA methyltransferase inhibitor, used for demethylation and gene expression modulation. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
A bromodomain inhibitor, affecting BET proteins, which are involved in gene transcription. | ||||||
BIX01294 hydrochloride | 1392399-03-9 | sc-293525 sc-293525A sc-293525B | 1 mg 5 mg 25 mg | $36.00 $110.00 $400.00 | ||
Inhibits G9a histone methyltransferase, altering histone methylation patterns. |